Exchange: NYSE·Updated 10:30 AM EDT
ANRO logo

ANROAlto Neuroscience Inc.

$26.69
$0.38
(1.40%)
Today
EarningsAug 12
Mkt Cap$1.05B
Vol14,878.00

About

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
68

Frequently Asked Questions

What is Market Cap of Alto Neuroscience Inc.?
What is the 52-week high for Alto Neuroscience Inc.?
What is the 52-week low for Alto Neuroscience Inc.?
What is Alto Neuroscience Inc. stock price today?
What was Alto Neuroscience Inc. stock price yesterday?
What is the PE ratio of Alto Neuroscience Inc.?
What is the Price-to-Book ratio of Alto Neuroscience Inc.?
What is the 50-day moving average of Alto Neuroscience Inc.?
How many employees does Alto Neuroscience Inc. have?

Advertisement|Remove ads.